The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Towards clinical utility of polygenic risk scores
Open accessAbstract
Prediction of disease risk is an essential part of preventative medicine, often guiding clinical management. Risk prediction typically includes risk factors such as age, sex, family history of disease and lifestyle (e.g. smoking status); however, in recent years, there has been increasing interest to include genomic information into risk models. Polygenic risk scores (PRS) aggregate the effects of many genetic variants across the human genome into a single score and have recently been shown to have predictive value for multiple common diseases. In this review, we summarize the potential use cases for seven common diseases (breast cancer, prostate cancer, coronary artery disease, obesity, type 1 diabetes, type 2 diabetes and Alzheimer’s disease) where PRS has or could have clinical utility. PRS analysis for these diseases frequently revolved around (i) risk prediction performance of a PRS alone and in combination with other non-genetic risk factors, (ii) estimation of lifetime risk trajectories, (iii) the independent information of PRS and family history of disease or monogenic mutations and (iv) estimation of the value of adding a PRS to specific clinical risk prediction scenarios. We summarize open questions regarding PRS usability, ancestry bias and transferability, emphasizing the need for the next wave of studies to focus on the implementation and health-economic value of PRS testing. In conclusion, it is becoming clear that PRS have value in disease risk prediction and there are multiple areas where this may have clinical utility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821 · cited 1×
“Initially, PRS tended to be constructed from genome-wide significant SNPs (typically, P<5x10), which for many diseases led to weakly predictive PRS as the number of genome-wide SNPs was small (11, 12).”
BackgroundBuniello, A., MacArthur, J. A. L., Cerezo, M., Harris, L. W., Hayhurst, J., Malangone, C., McMahon, A., Morales, J., Mountjoy, E., Sollis, E., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1120 · Cited by 4,000
10 Years of GWAS Discovery: Biology, Function, and Translation
Visscher, P. M., Wray, N. R., Zhang, Q., Sklar, P., McCarthy, M. I., Brown, M. A., & Yang, J. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.06.005 · Cited by 3,719 · cited 1×
“Typically, these scores include hundreds-to-thousands of SNPs, motivated by theory and data showing that many diseases are polygenic (7).”
BackgroundIntegrating common and rare genetic variation in diverse human populations
The International HapMap 3 Consortium (2010) · Nature · doi:10.1038/nature09298 · Cited by 3,026
Khera, A. V., Chaffin, M., Aragam, K. G., Haas, M. E., Roselli, C., Choi, S. H., Natarajan, P., Lander, E. S., Lubitz, S. A., Ellinor, P. T., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0183-z · Cited by 2,953 · cited 2×
“For example, the top 8% CAD PRS confers an odds ratio of 3, which is similar to that of FH (38, 39), but far more prevalent (1 in 13 and 1 in 200 for the PRS top 8% and FH, respectively), thus representing a much higher disease burden on the”
MethodClinical use of current polygenic risk scores may exacerbate health disparities
Martin, A. R., Kanai, M., Kamatani, Y., Okada, Y., Neale, B. M., & Daly, M. J. (2019) · Nature Genetics · doi:10.1038/s41588-019-0379-x · Cited by 2,821
Tutorial: a guide to performing polygenic risk score analyses
Choi, S. W., Mak, T. S.-H., & O’Reilly, P. F. (2020) · Nature Protocols · doi:10.1038/s41596-020-0353-1 · Cited by 1,946
The personal and clinical utility of polygenic risk scores
Torkamani, A., Wineinger, N. E., & Topol, E. J. (2018) · Nature Reviews Genetics · doi:10.1038/s41576-018-0018-x · Cited by 1,623
Power and predictive accuracy of polygenic risk scores
Dudbridge, F. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003348 · Cited by 1,509
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Grossman, D. C., Curry, S. J., Owens, D. K., Bibbins-Domingo, K., Caughey, A. B., Davidson, K. W., Doubeni, C. A., Ebell, M., Epling, J. W., et al. (2018) · JAMA · doi:10.1001/jama.2018.3710 · Cited by 1,436
Human Demographic History Impacts Genetic Risk Prediction across Diverse Populations
Martin, A. R., Gignoux, C. R., Walters, R. K., Wojcik, G. L., Neale, B. M., Gravel, S., Daly, M. J., Bustamante, C. D., & Kenny, E. E. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.03.004 · Cited by 1,391
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Vilhjálmsson, B. J., Yang, J., Finucane, H. K., Gusev, A., Lindström, S., Ripke, S., Genovese, G., Loh, P.-R., Bhatia, G., Do, R., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.09.001 · Cited by 1,303
New approaches to population stratification in genome-wide association studies
Price, A. L., Zaitlen, N. A., Reich, D., & Patterson, N. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2813 · Cited by 1,205
Ilic, D., Neuberger, M. M., Djulbegovic, M., & Dahm, P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004720.pub3 · Cited by 1,150
Multi-trait analysis of genome-wide association summary statistics using MTAG
23andMe Research Team, Turley, P., Social Science Genetic Association Consortium, Walters, R. K., Maghzian, O., Okbay, A., Lee, J. J., Fontana, M. A., Nguyen-Viet, T. A., Wedow, R., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0009-4 · Cited by 1,112 · cited 1×
“but consistent gains in predictive power (88, 89).”
BackgroundPolygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
Mavaddat, N., Michailidou, K., Dennis, J., Lush, M., Fachal, L., Lee, A., Tyrer, J. P., Chen, T.-H., Wang, Q., Bolla, M. K., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.11.002 · Cited by 1,097
DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) Consortium, Mahajan, A., Asian Genetic Epidemiology Network Type 2 Diabetes (AGEN-T2D) Consortium, South Asian Type 2 Diabetes (SAT2D) Consortium, Mexican American Type 2 Diabetes (MAT2D) Consortium, Type 2 Diabetes Genetic Exploration by Next-generation sequencing in multi-Ethnic Samples (T2D-GENES) Consortium, Go, M. J., Zhang, W., Below, J. E., Gaulton, K. J., et al. (2014) · Nature Genetics · doi:10.1038/ng.2897 · Cited by 1,034
Genetic analyses of diverse populations improves discovery for complex traits
Wojcik, G. L., Graff, M., Nishimura, K. K., Tao, R., Haessler, J., Gignoux, C. R., Highland, H. M., Patel, Y. M., Sorokin, E. P., Avery, C. L., et al. (2019) · Nature · doi:10.1038/s41586-019-1310-4 · Cited by 1,033
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults
Inouye, M., Abraham, G., Nelson, C. P., Wood, A. M., Sweeting, M. J., Dudbridge, F., Lai, F. Y., Kaptoge, S., Brozynska, M., Wang, T., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.079 · Cited by 793
Self-citationPolygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood
Khera, A. V., Chaffin, M., Wade, K. H., Zahid, S., Brancale, J., Xia, R., Distefano, M., Senol-Cosar, O., Haas, M. E., Bick, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.028 · Cited by 789
Lee, A., Mavaddat, N., Wilcox, A. N., Cunningham, A. P., Carver, T., Hartley, S., Babb de Villiers, C., Izquierdo, A., Simard, J., Schmidt, M. K., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0406-9 · Cited by 721
Mega, J. L., Stitziel, N. O., Smith, J. G., Chasman, D. I., Caulfield, M. J., Devlin, J. J., Nordio, F., Hyde, C. L., Cannon, C. P., Sacks, F. M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61730-x · Cited by 704
Developing and evaluating polygenic risk prediction models for stratified disease prevention
Chatterjee, N., Shi, J., & García-Closas, M. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.27 · Cited by 697
Natarajan, P., Young, R., Stitziel, N. O., Padmanabhan, S., Baber, U., Mehran, R., Sartori, S., Fuster, V., Reilly, D. F., Butterworth, A., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024436 · Cited by 570
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
Mavaddat, N., Pharoah, P. D. P., Michailidou, K., Tyrer, J., Brook, M. N., Bolla, M. K., Wang, Q., Dennis, J., Dunning, A. M., Shah, M., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv036 · Cited by 550
Recovery of trait heritability from whole genome sequence data
Wainschtein, P., Jain, D., Zheng, Z., TOPMed Anthropometry Working Group, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Cupples, L. A., Shadyab, A. H., McKnight, B., Shoemaker, B. M., Mitchell, B. D., et al. (2019) · doi:10.1101/588020 · Cited by 515
Wainschtein, P., Jain, D., Zheng, Z., TOPMed Anthropometry Working Group, Aslibekyan, S., Becker, D., Bi, W., Brody, J., Carlson, J. C., Correa, A., et al. (2022) · Nature Genetics · doi:10.1038/s41588-021-00997-7 · Cited by 513
Polygenic scores via penalized regression on summary statistics
Mak, T. S. H., Porsch, R. M., Choi, S. W., Zhou, X., & Sham, P. C. (2017) · Genetic Epidemiology · doi:10.1002/gepi.22050 · Cited by 493
Dissecting the genetics of complex traits using summary association statistics
Pasaniuc, B., & Price, A. L. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.142 · Cited by 457
Common polygenic variation enhances risk prediction for Alzheimer’s disease
Escott-Price, V., Sims, R., Bannister, C., Harold, D., Vronskaya, M., Majounie, E., Badarinarayan, N., GERAD/PERADES, consortia, I., Morgan, K., et al. (2015) · Brain · doi:10.1093/brain/awv268 · Cited by 414
Desikan, R. S., Fan, C. C., Wang, Y., Schork, A. J., Cabral, H. J., Cupples, L. A., Thompson, W. K., Besser, L., Kukull, W. A., Holland, D., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002258 · Cited by 395 · cited 2×
“Potential clinical utility for PRS Current polygenic scores can explain the majority of heritability for common variants (95) Polygenic Hazard Scores (PHS) to estimate age-of-onset (30) D ow naded rom http/academ ic.”
BackgroundSharp, S. A., Rich, S. S., Wood, A. R., Jones, S. E., Beaumont, R. N., Harrison, J. W., Schneider, D. A., Locke, J. M., Tyrrell, J., Weedon, M. N., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1785 · Cited by 366
Chatterjee, N., Wheeler, B., Sampson, J., Hartge, P., Chanock, S. J., & Park, J.-H. (2013) · Nature Genetics · doi:10.1038/ng.2579 · Cited by 362
Genomic prediction of coronary heart disease
Abraham, G., Havulinna, A. S., Bhalala, O. G., Byars, S. G., De Livera, A. M., Yetukuri, L., Tikkanen, E., Perola, M., Schunkert, H., Sijbrands, E. J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw450 · Cited by 338
Self-citationThe genetic interpretation of area under the ROC curve in genomic profiling
Wray, N. R., Yang, J., Goddard, M. E., & Visscher, P. M. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000864 · Cited by 334 · cited 1×
“Under an additive genetic liability threshold model, by assuming several key quantities, including population prevalence K, heritability h(2) (on the liability scale) (and/or the sibling recurrence risk λs), we can derive the expected predictive power of a PRS, measured in sensitivity, specificity, AUC, and other quan…”
BackgroundKuchenbaecker, K. B., McGuffog, L., Barrowdale, D., Lee, A., Soucy, P., Dennis, J., Domchek, S. M., Robson, M., Spurdle, A. B., Ramus, S. J., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw302 · Cited by 327
Khera, A. V., Chaffin, M., Zekavat, S. M., Collins, R. L., Roselli, C., Natarajan, P., Lichtman, J. H., D’Onofrio, G., Mattera, J., Dreyer, R., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.035658 · Cited by 315
Apparent latent structure within the UK Biobank sample has implications for epidemiological analysis
Haworth, S., Mitchell, R., Corbin, L., Wade, K. H., Dudding, T., Budu-Aggrey, A., Carslake, D., Hemani, G., Paternoster, L., Smith, G. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08219-1 · Cited by 314
Genomics of disease risk in globally diverse populations
Gurdasani, D., Barroso, I., Zeggini, E., & Sandhu, M. S. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0144-0 · Cited by 306
The role of sex in the genomics of human complex traits
Khramtsova, E. A., Davis, L. K., & Stranger, B. E. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0083-1 · Cited by 303
Predicting Polygenic Risk of Psychiatric Disorders
Martin, A. R., Daly, M. J., Robinson, E. B., Hyman, S. E., & Neale, B. M. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.12.015 · Cited by 299
van der Lee, S. J., Wolters, F. J., Ikram, M. K., Hofman, A., Ikram, M. A., Amin, N., & van Duijn, C. M. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30053-x · Cited by 298
Evans, D. M., Visscher, P. M., & Wray, N. R. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp295 · Cited by 297
Tada, H., Melander, O., Louie, J. Z., Catanese, J. J., Rowland, C. M., Devlin, J. J., Kathiresan, S., & Shiffman, D. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv462 · Cited by 285
Pashayan, N., Morris, S., Gilbert, F. J., & Pharoah, P. D. P. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1901 · Cited by 284
Kullo, I. J., Jouni, H., Austin, E. E., Brown, S.-A., Kruisselbrink, T. M., Isseh, I. N., Haddad, R. A., Marroush, T. S., Shameer, K., Olson, J. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.020109 · Cited by 267
Shieh, Y., Eklund, M., Madlensky, L., Sawyer, S. D., Thompson, C. K., Stover Fiscalini, A., Ziv, E., van’t Veer, L. J., Esserman, L. J., & Tice, J. A. (2017) · Journal of the National Cancer Institute · doi:10.1093/jnci/djw290 · Cited by 240
Identification of Novel Genetic Markers of Breast Cancer Survival
Guo, Q., Schmidt, M. K., Kraft, P., Canisius, S., Chen, C., Khan, S., Tyrer, J., Bolla, M. K., Wang, Q., Dennis, J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv081 · Cited by 235
Morales, J., Welter, D., Bowler, E. H., Cerezo, M., Harris, L. W., McMahon, A. C., Hall, P., Junkins, H. A., Milano, A., Hastings, E., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1396-2 · Cited by 217
Seibert, T. M., Fan, C. C., Wang, Y., Zuber, V., Karunamuni, R., Parsons, J. K., Eeles, R. A., Easton, D. F., Kote-Jarai, Z., Al Olama, A. A., et al. (2018) · BMJ · doi:10.1136/bmj.j5757 · Cited by 215
Genetic disease risks can be misestimated across global populations
Kim, M. S., Patel, K. P., Teng, A. K., Berens, A. J., & Lachance, J. (2018) · Genome Biology · doi:10.1186/s13059-018-1561-7 · Cited by 210
Causal relationships between obesity and the leading causes of death in women and men
Censin, J. C., Peters, S. A. E., Bovijn, J., Ferreira, T., Pulit, S. L., Mägi, R., Mahajan, A., Holmes, M. V., & Lindgren, C. M. (2019) · PLOS Genetics · doi:10.1371/journal.pgen.1008405 · Cited by 203
Waters, K. M., Stram, D. O., Hassanein, M. T., Le Marchand, L., Wilkens, L. R., Maskarinec, G., Monroe, K. R., Kolonel, L. N., Altshuler, D., Henderson, B. E., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001078 · Cited by 191
Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease
Escott-Price, V., Shoai, M., Pither, R., Williams, J., & Hardy, J. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.018 · Cited by 183
Lecarpentier, J., Silvestri, V., Kuchenbaecker, K. B., Barrowdale, D., Dennis, J., McGuffog, L., Soucy, P., Leslie, G., Rizzolo, P., Navazio, A. S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.4935 · Cited by 178
Redondo, M. J., Geyer, S., Steck, A. K., Sharp, S., Wentworth, J. M., Weedon, M. N., Antinozzi, P., Sosenko, J., Atkinson, M., Pugliese, A., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0087 · Cited by 174
Personalized risk prediction for type 2 diabetes: the potential of genetic risk scores
Läll, K., Mägi, R., Morris, A. P., Metspalu, A., & Fischer, K. (2016) · Genetics in Medicine · doi:10.1038/gim.2016.103 · Cited by 165
Improving genetic prediction by leveraging genetic correlations among human diseases and traits
Maier, R. M., Zhu, Z., Lee, S. H., Trzaskowski, M., Ruderfer, D. M., Stahl, E. A., Ripke, S., Wray, N. R., Yang, J., Visscher, P. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02769-6 · Cited by 164
Bonifacio, E., Beyerlein, A., Hippich, M., Winkler, C., Vehik, K., Weedon, M. N., Laimighofer, M., Hattersley, A. T., Krumsiek, J., Frohnert, B. I., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002548 · Cited by 148
Brandkvist, M., Bjørngaard, J. H., Ødegård, R. A., Åsvold, B. O., Sund, E. R., & Vie, G. Å. (2019) · BMJ · doi:10.1136/bmj.l4067 · Cited by 137
Önengüt-Gümüşcü, S., Chen, W., Robertson, C. C., Bonnie, J. K., Farber, E., Zhu, Z., Oksenberg, J. R., Brant, S. R., Bridges, S. L., Edberg, J. C., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1727 · Cited by 134
Curtis, D. (2018) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000206 · Cited by 132
Kensler, K. H., Regan, M. M., Heng, Y. J., Baker, G. M., Pyle, M. E., Schnitt, S. J., Hazra, A., Kammler, R., Thurlimann, B. J. K., Colleoni, M. A., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1118-z · Cited by 131
Genomic risk prediction of complex human disease and its clinical application
Abraham, G., & Inouye, M. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.06.005 · Cited by 128
Self-citationComparison of Family History and SNPs for Predicting Risk of Complex Disease
Do, C. B., Hinds, D. A., Francke, U., & Eriksson, N. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002973 · Cited by 127
Complex Trait Prediction from Genome Data: Contrasting EBV in Livestock to PRS in Humans
Wray, N. R., Kemper, K. E., Hayes, B. J., Goddard, M. E., & Visscher, P. M. (2019) · Genetics · doi:10.1534/genetics.119.301859 · Cited by 126
Sporadic cases are the norm for complex disease
Yang, J., Visscher, P. M., & Wray, N. R. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.177 · Cited by 124
Heterogeneity in polygenic scores for common human traits
Ware, E. B., Schmitz, L. L., Faul, J., Gard, A., Mitchell, C., Smith, J. A., Zhao, W., Weir, D., & Kardia, S. L. (2017) · doi:10.1101/106062 · Cited by 123
Dite, G. S., MacInnis, R. J., Bickerstaffe, A., Dowty, J. G., Allman, R., Apicella, C., Milne, R. L., Tsimiklis, H., Phillips, K., Giles, G. G., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0838 · Cited by 123
Geographic Variation and Bias in the Polygenic Scores of Complex Diseases and Traits in Finland
Kerminen, S., Martin, A. R., Koskela, J. T., Ruotsalainen, S., Havulinna, A. S., Surakka, I. L., Palotie, A. V., Perola, M., Salomaa, V. V., Daly, M. J., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.05.001 · Cited by 122
Zhang, X., Rice, M. S., Tworoger, S. S., ROSNER, B. A., Eliassen, A. H., Tamimi, R. M., Joshi, A. D., Lindström, S., Qian, J., Colditz, G. A., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002644 · Cited by 120
Geographic variation and bias in polygenic scores of complex diseases and traits in Finland
Kerminen, S., Martin, A. R., Koskela, J., Ruotsalainen, S. E., Havulinna, A. S., Surakka, I., Palotie, A., Perola, M., Salomaa, V., Daly, M. J., et al. (2018) · doi:10.1101/485441 · Cited by 115
Paquette, M., Chong, M., Thériault, S., Dufour, R., Paré, G., & Baass, A. (2017) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.03.019 · Cited by 115
Rudolph, A., Song, M., Brook, M. N., Milne, R. L., Mavaddat, N., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Hurson, A. N., et al. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx242 · Cited by 110
Stocker, H. R., Möllers, T., Perna, L., & Brenner, H. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0221-8 · Cited by 107
On the utilization of polygenic risk scores for therapeutic targeting
Gibson, G. C. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008060 · Cited by 107
Polygenic hazard score: an enrichment marker for Alzheimer’s associated amyloid and tau deposition
Initiative, A. D. N., Tan, C. H., Fan, C. C., Mormino, E. C., Sugrue, L. P., Broce, I., Hess, C. P., Dillon, W. P., Bonham, L. W., Yokoyama, J. S., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1789-4 · Cited by 100
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
Pashayan, N., Duffy, S. W., Neal, D. E., Hamdy, F. C., Donovan, J., Martin, R. M., Harrington, P. A., Benlloch, S., Olama, A. A. A., Shah, M., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.192 · Cited by 93
Perry, D. J., Wasserfall, C. H., Oram, R. A., Williams, M. D., Posgai, A. L., MUIR, A. B., Haller, M. J., Schatz, D., Wallet, M. A., Mathews, C. E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22574-5 · Cited by 89
Comparative genetic architectures of schizophrenia in East Asian and European populations
Schizophrenia Working Group of the Psychiatric Genomics Consortium, Chen, C.-Y., Li, Z., Martin, A. R., Bryois, J., Ma, X., Gaspar, H. A., Ikeda, M., Benyamin, B., Brown, B. C., et al. (2019) · Lancaster EPrints (Lancaster University) · Cited by 83
Reisberg, S., Iljasenko, T., Läll, K., Fischer, K., & Vilo, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179238 · Cited by 79
Polygenic hazard scores in preclinical Alzheimer disease
Tan, C. H., Hyman, B. T., Tan, J. J. X., Hess, C. P., Dillon, W. P., Schellenberg, G. D., Besser, L. M., Kukull, W. A., Kauppi, K., McEvoy, L. K., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25029 · Cited by 68
Longitudinal Analysis of Genetic Susceptibility and BMI Throughout Adult Life
Song, M., Zheng, Y., Qi, L., Hu, F. B., Chan, A. T., & Giovannucci, E. L. (2017) · Diabetes · doi:10.2337/db17-1156 · Cited by 56
Läll, K., Lepamets, M., Palover, M., Esko, T., Metspalu, A., Tõnisson, N., Padrik, P., Mägi, R., & Fischer, K. (2019) · BMC Cancer · doi:10.1186/s12885-019-5783-1 · Cited by 49
Pashayan, N., Pharoah, P. D. P., Schleutker, J., Talala, K. M., Tammela, T. L. J., Määttänen, L., Harrington, P. A., Tyrer, J. P., Eeles, R. A., Duffy, S. W., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.289 · Cited by 46
on behalf of the China Kadoorie Biobank Collaborative Group, Gan, W., Walters, R. G., Holmes, M. V., Bragg, F., Millwood, I. Y., Banasik, K., Chen, Y., Du, H., Iona, A., et al. (2016) · Diabetologia · doi:10.1007/s00125-016-3920-9 · Cited by 46
Polygenic Risk Scoring for Coronary Heart Disease
Natarajan, P. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.1041 · Cited by 43
Vachon, C. M., Scott, C. G., Tamimi, R. M., Thompson, D. J., Fasching, P. A., Stone, J., Southey, M. C., Winham, S. J., Lindström, S., Lilyquist, J., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1138-8 · Cited by 43
Lakeman, I. M. M., Hilbers, F., Rodríguez‐Girondo, M., Lee, A. S., Vreeswijk, M. P. G., Hollestelle, A., Seynaeve, C., Meijers-Heijboer, H. E. J., Oosterwijk, J. C., Hoogerbrugge, N., et al. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106072 · Cited by 43
So, H., & Sham, P. C. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001230 · Cited by 40
Hindy, G., Wiberg, F., Almgren, P., Melander, O., & Orho‐Melander, M. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.117.001856 · Cited by 36
Genetic Testing to Guide Risk-Stratified Screens for Breast Cancer
Willoughby, A., Andreassen, P. R., & Toland, A. E. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9010015 · Cited by 34
Value of genetic testing in the prevention of coronary heart disease events
Hynninen, Y., Linna, M., & Vilkkumaa, E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210010 · Cited by 25
A polygenic risk score for breast cancer in U.S. Latinas and Latin-American womenPreprint
Shieh, Y., Fejerman, L., Lott, P. C., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/598730 · Cited by 21
Weedon, M. N., Jackson, L., Harrison, J. W., Ruth, K. S., Tyrrell, J., Hattersley, A. T., & Wright, C. F. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/696799 · Cited by 19
Validation of a genetic risk score for Arkansas women of color
Starlard‐Davenport, A., Allman, R., Dite, G. S., Hopper, J. L., Spaeth, E. L., Macleod, S. L., Kadlubar, S. A., Preston, M. A., & Henry‐Tillman, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204834 · Cited by 19
Fung, S. M., Wong, X. Y., Lee, S. X., Miao, H., Hartman, M., & Wee, H. L. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0810 · Cited by 18
Comparative genetic architectures of schizophrenia in East Asian and European populationsPreprint
Lam, M., Chen, C.-Y., Li, Z., Martin, A. R., Bryois, J., Ma, X., Gaspar, H., Ikeda, M., Benyamin, B., Brown, B. C., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/445874 · Cited by 17
Evaluation of Common Type 2 Diabetes Risk Variants in a South Asian Population of Sri Lankan Descent
Hassanali, N., Silva, N. M. G. D., Robertson, N., Rayner, N. W., Barrett, A., Bennett, A. J., Groves, C. J., Matthews, D. R., Katulanda, P., Frayling, T. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098608 · Cited by 12
Cited by
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Tutorial: a guide to performing polygenic risk score analyses
Choi, S. W., Mak, T. S.-H., & O’Reilly, P. F. (2020) · Nature Protocols · doi:10.1038/s41596-020-0353-1 · Cited by 1,946
Crosby, D., Bhatia, S., Brindle, K. M., Coussens, L. M., Dive, C., Emberton, M., Esener, S., Fitzgerald, R. C., Gambhir, S. S., Kuhn, P., et al. (2022) · Science · doi:10.1126/science.aay9040 · Cited by 1,379
“Currently, very few high-risk single genes (such as BRCA1 and BRCA2 ) trigger such action; increasingly the risk conferred by multiple genetic variants (called polygenic risk score) is being explored ( 39 ).”
Polygenic risk scores: from research tools to clinical instruments
Lewis, C. M., & Vassos, E. (2020) · Genome Medicine · doi:10.1186/s13073-020-00742-5 · Cited by 1,360
Improving polygenic prediction in ancestrally diverse populations
Ruan, Y., Lin, Y.-F., Feng, Y.-C. A., Chen, C.-Y., Lam, M., Guo, Z., Initiatives, S. G. A., Ahn, Y. M., Akiyama, K., Arai, M., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01054-7 · Cited by 707
Metadata
- Authors
- Lambert, S. A., Abraham, G., & Inouye, M.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07-31
- Volume
- 28
- Issue
- R2
- Pages
- R133-R142
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2980086570
- Cited by
- 575
- References
- 101
- FWCI
- 36.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.